Cinctive Capital Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.9M Buy
172,996
+141,294
+446% +$12.4M 0.58% 44
2026
Q1
$2.7M Buy
31,702
+5,772
+22% +$514K 0.18% 180
2025
Q4
$2.05M Buy
+25,930
New +$2.03M 0.11% 207
2024
Q3
Sell
-9,507
Closed -$923K 406
2024
Q2
$923K Buy
+9,507
New +$877K 0.04% 320
2023
Q3
Sell
-27,178
Closed -$2.09M 380
2023
Q2
$2.09M Sell
27,178
-114,023
-81% -$8.83M 0.07% 265
2023
Q1
$10.6M Buy
+141,201
New +$10.5M 0.35% 89
2022
Q3
Sell
-65,456
Closed -$5.25M 482
2022
Q2
$5.25M Buy
+65,456
New +$5.12M 0.22% 148
2021
Q2
Sell
-43,895
Closed -$3.46M 520
2021
Q1
$3.46M Buy
+43,895
New +$3.44M 0.21% 183

Other funds holding CL

Cinctive Capital Management's CL Position: Q2 2026 in Review

Cinctive Capital Management increased its Colgate-Palmolive (CL) stake by 446% in Q2 2026, buying an estimated $12.4M and bringing the position to 172,996 shares worth $15.9M. The position accounts for 0.58% of the portfolio, ranked #44.

Cinctive Capital Management first reported a position in CL in Q1 2021 and has held it in 8 quarters since. 2,023 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Cinctive Capital Management held 172,996 shares of Colgate-Palmolive worth $15.9M as of Q2 2026.
  • Cinctive Capital Management bought 141,294 Colgate-Palmolive shares in Q2 2026, an estimated $12.4M.
  • Colgate-Palmolive made up 0.58% of Cinctive Capital Management's portfolio in Q2 2026, its #44 holding.
  • Cinctive Capital Management first reported a position in Colgate-Palmolive in Q1 2021 and has held it in 8 quarters since.
  • 2,023 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Cinctive Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.